Cargando…
Social App to Improve Warfarin Therapy in Post-MHVR Chinese Patients: A Randomized Controlled Trial
BACKGROUND: Poor anticoagulation quality was a major problem among warfarin-treated patients, which called for innovative and effective methods to improve it. OBJECTIVE: To investigate whether social app could be used to reduce warfarin-associated adverse events among post-MHVR Chinese patients. MET...
Autores principales: | Zhang, Litao, Li, Sha, Li, Zishuo, Yu, Dan, Wu, Haiyan, Hua, Bing, Xie, Li, Yuan, Xia, Li, Yun, Zhang, Zhenlu, Long, Yanli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9867580/ https://www.ncbi.nlm.nih.gov/pubmed/36714197 http://dx.doi.org/10.1155/2023/2342111 |
Ejemplares similares
-
Warfarin Dosage Response Related Pharmacogenetics in Chinese Population
por: Li, Siyue, et al.
Publicado: (2015) -
Standardization of D‐dimer reporting in the COVID‐19 era
por: Zhang, Litao, et al.
Publicado: (2022) -
Uncertainties on the prognostic value of admission D‐dimer on venous thromboembolism occurrence in patients with COVID‐19
por: Zhang, Litao, et al.
Publicado: (2022) -
How to use and report data on D‐dimer testing in the COVID‐19 era?
por: Zhang, Litao, et al.
Publicado: (2022) -
Plasma miRNA profiles associated with stable warfarin dosage in Chinese patients
por: Zhao, Li, et al.
Publicado: (2020)